This inventor holds 3 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1982-1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982-1984
Title: The Innovative Contributions of Nobuo Nakamura in Antibacterial Compounds
Introduction: Nobuo Nakamura, based in Machida, Japan, is a distinguished inventor known for his significant contributions to the field of antibacterial compounds. With a total of three patents to his name, Nakamura has made remarkable strides in the development of antibiotic solutions that address pressing medical needs.
Latest Patents: Among Nakamura's most notable inventions are two latest patents. The first, the "Compound DC-38-V and process for production thereof," involves the production of an antibacterial compound, DC-38-V, derived from culturing a microorganism of the genus Streptomyces. The second, titled "Antibiotic DC-11 and process for production thereof," introduces a new antibacterial compound, DC-11, which is produced through fermentation of a microorganism belonging to the genus Micromonospora. This innovative antibiotic is accumulated in the culture medium and isolated for application, showcasing Nakamura's commitment to advancing antibiotic research.
Career Highlights: Nobuo Nakamura currently holds his position at Kyowa Hakko Kogyo Co., Ltd., a respected company in the field of biotechnology. His career has been marked by a focus on developing effective antibacterial solutions, significantly benefiting both the medical community and patients in need of novel treatments.
Collaborations: Throughout his career, Nakamura has had the opportunity to collaborate with esteemed colleagues, including Fusao Tomita and Shuji Okubo. These partnerships have further enriched his research endeavors and the innovative work being pursued at Kyowa Hakko Kogyo Co., Ltd.
Conclusion: Nobuo Nakamura exemplifies the spirit of innovation in the biotechnology sector. His efforts in developing new antibacterial compounds through his patents reflect a dedication to addressing crucial health challenges. As the need for effective antibiotics continues to rise, Nakamura's contributions remain vital to advancing medical treatments in today's world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile